HSA grants interim authorisation for oral Covid-19 drug molnupiravir - TODAY
4/19/2022 12:00:00 AM3 years 10 months ago
SINGAPORE — The Health Sciences Authority (HSA) on Tuesday (April 19) granted interim authorisation for the use of molnupiravir as an oral treatment for mild to moderate Covid-19.
SINGAPORE The Health Sciences Authority (HSA) on Tuesday (April 19) granted interim authorisation for the use of molnupiravir as an oral treatment for mild to moderate Covid-19. This decision was m… [+4244 chars]
full article...